A new, generic, non-steroidal anti-inflammatory drug (NSAID) is now available for managing osteoarthritis (OA) pain in horses ...

Boehringer will leverage ExpressionEdits' Genetic Syntax Engine which generates optimized introns to increase protein expression.

Signs a tooth infection has spread include symptoms such as a painful tongue and mouth, swelling of the face, cheeks, or neck, and difficulty swallowing. Can a tooth infection affect the whole body?

Persistent bone pain, swelling and a noticeable lump over a bone are all tell-tale signs. Around 550 new cases of the rare bone cancer are diagnosed each year in the UK. But for many the survival ...

One of the foremost signs of bone cancer is pain. The organisation elaborates: "You might have pain or tenderness most of the time, even when you're resting. The pain is often worse in bed at night.

Signs of the disease - which affects the 'neck of the womb' - can crop up during the most intimate moments. For example, sharp pain or deep discomfort during sex can be a key red flag of cervical ...

BI-765845 is under clinical development by Boehringer Ingelheim International and currently in Phase II for Myocardial Infarction. According to GlobalData, Phase II drugs for Myocardial Infarction ...

A solid and productive year is guaranteed by their tenacity and pragmatic outlook. ALSO READ: Chinese zodiac sign 2025: These zodiac signs are likely to taste success in the year 2025. Here are the ...

Boehringer Ingelheim’s trio of late-stage schizophrenia failures on Thursday came a day after the Department of Health and Human Services hit back on the pharma’s legal challenge to the IRA’s drug ...

When Symptoms Warrant a Provider Visit Foot symptoms warrant a healthcare provider visit if the problem persists for more than a few days, shows signs of infection, or involves the inability to stand ...

HHS told the Sec­ond Cir­cuit that Boehringer In­gel­heim’s vol­un­tary par­tic­i­pa­tion in Medicare ne­go­ti­a­tions “un­der­mines” its le­gal chal­lenge to the process.

Boehringer Ingelheim As one of the industry's top investors in Research and Development, the company focuses on developing innovative therapies in areas of high unmet medical need.